Molecular epidemiology of hepatitis B virus vaccine variants in Singapore

By Oon C.-J.   Lim G.-K.   Ye Z.   Goh K.-T.   Tan K.-L.   Yo S.-L.   Hopes E.   Harrison T.J.   Zuckerman A.J.  

Vaccine, Vol. 13, Iss. 8, 1995-06 ,pp. : 699-702

Elsevier

Access to resources Recommend Favorite

The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design

By Chao Z.   Cornette J.L.   Berzofsky J.A.   DeLisi C.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1291-1302

Elsevier

Access to resources Recommend Favorite

Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials

By Agwale S.M.   Zeh C.   Robbins K.E.   Odama L.   Saekhou A.   Edubio A.   Njoku M.   Sani-Gwarzo N.   Gboun M.S.   Gao F.   Reitz M.   Hone D.   Pieniazek D.   Wambebe C.   Kalish M.L.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2131-2139

Elsevier

Access to resources Recommend Favorite

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

By Heath D.G.   Anderson G.W.   Mauro J.M.   Welkos S.L.   Andrews G.P.   Adamovicz J.   Friedlander A.M.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1131-1137

Elsevier

Access to resources Recommend Favorite

A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans

By Cryz S.J.   Que J.U.   Gluck R.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1381-1383

Elsevier

Access to resources Recommend Favorite